Australian Health Journal met with Commissioner Catherine de Fontenay from the Productivity Commission to discuss the key findings of new research papers, “Advances in Measuring Healthcare Productivity”, released in April and in May, the release of “Making the most of Technology in Healthcare”.
De Fontenay talks about the Commission’s new approach to analysing health productivity, shifting the perspective from the unit measurement of individuals using the health system to the actual improvement of health. This has shown Australia’s health treatment productivity is improving, but identifies gaps in preventative health measures and duplication, where digital technology needs to be more effectively used.
The “Advances in Measuring Healthcare Productivity” research paper emphasises the productivity of healthcare by examining the outcomes of health treatments, such as those for lung cancer, and exploring the possibility of lower-cost settings for treatment, such as home-based care. This approach resulted in a notable 3% increase in productivity annually, showing improved health outcomes and enhanced value for money.
While the research highlights the improving productivity of health treatments, it also emphasises the importance of addressing the factors leading to illness, particularly in light of Australia’s high rates of obesity and alcohol consumption. By tackling these issues, substantial reductions in healthcare costs can be achieved. The research also identifies digital technologies as a promising avenue for cost reduction in healthcare, particularly in minimising excess testing and delivering care in more cost-effective settings.
When accounting for health risks in the population, Australia ranks third among 28 comparable high-income countries in terms of healthcare value for money, indicating the country’s strong performance using this method of measurement.
The second research paper “Making the most of Technology in Healthcare”, underscores the detrimental impact of inadequate electronic medical records on patient care quality, citing preventable medication-related errors costing approximately $1.4 billion annually. Additionally, it emphasises the significance of effective electronic discharge processes from hospitals in reducing the risk of readmission.
The research has advocated for the effective utilisation of digital technologies, including electronic medical records, telehealth, remote care, and artificial intelligence, in the healthcare system. It highlights the potential of these technologies to significantly reduce costs, citing potential savings of about $5 billion for hospitals by reducing test duplication and expediting patient discharge.
Remote monitoring technologies can reduce complications for high-risk diabetes patients, but funding structures need to be improved to maximise their benefits. To that end, the research emphasises the potential of digital technologies to revolutionise the healthcare system, provided that effective utilisation and appropriate funding structures are in place.
You Might also like
-
Brain and Mind Implants Lived Experience Medical Technology Nervous System New Content New South Wales Spinal cord
LIVED EXPERIENCE: Complex Regional Pain Syndrome (CRPS)
Lachlan Thorpe has shared his experience of living with complex regional pain syndrome (CRPS), highlighting the profound impact the condition had on his life and the difference medical technology has made to his recovery.
In an interview with the Australian Health Journal, Thorpe explained that his CRPS developed following an ankle injury sustained while playing rugby for Sydney University Rugby Club in late 2024. After undergoing surgery and rehabilitation for the injury, he began experiencing severe pain, swelling and sensitivity despite there being no further orthopaedic damage.
-
Evolution in consumer diagnostics with saliva based pathology
Since the COVID-19 pandemic, consumer diagnostics have rapidly advanced, with more people becoming aware of and comfortable using at-home testing. These tests provide greater convenience, control, and empowerment, allowing individuals to monitor their health without immediately consulting a healthcare professional. Recently, this shift has been particularly impactful in areas such as pregnancy testing, where saliva-based diagnostics now enable earlier and more accessible detection.
-
Understanding extracellular vesicles in cancer therapy research
Joy Wolfram is an Associate Professor at the Australian Institute for Bioengineering and Nanotechnology and the School of Chemical Engineering at the University of Queensland in Australia. Originally from Finland, she earned both her bachelor’s and master’s degrees in biology before transitioning to engineering with a PhD in nanotechnology completed in China. Wolfram has over a decade of experience working in hospitals in the United States before joining the University of Queensland.
Her research focuses on extracellular vesicles, which are crucial for cell communication both locally within tissues and over longer distances between organs. Her lab studies the roles of these vesicles in both health and disease, particularly in cancer. They investigate the harmful messages released by cancer cells that aid in tumour growth, specifically in breast cancer, while also exploring how to harness beneficial extracellular vesicles from healthy individuals as potential therapeutics.